Skip to content

Diabetes Sleep Treatment Trial for Insomnia

Self-Management, Insomnia, and Glucose Control in Adults With Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03064321
Acronym
DSTT-I
Enrollment
18
Registered
2017-02-27
Start date
2017-11-01
Completion date
2020-03-30
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Insomnia

Keywords

cognitive behavioral treatment

Brief summary

This study will test the effect of the an insomnia intervention with cognitive behavioral treatment delivered via web compared with an information control group on glucose control and self management behavioral in a sample of persons with type 2 diabetes (T2DM).

Detailed description

Recent evidence supports that insomnia is a prevalent problem among persons with type 2 diabetes that may be associated with increased daytime sleepiness and fatigue, increased diabetes-related distress, decreased self-management behavior, and worse glycemic control. The main hypothesis of the current application is that a web-based cognitive behavioral treatment of insomnia (Sleep Health Using the Internet: SHUTi) in persons with T2DM will not only improve their nighttime sleep, but also improve their ability to integrate diabetes education into their daily behavior and positively affect their glucose control compared to a web-based Information Control (IC) group. The aims of this study are to 1) obtain preliminary data to facilitate further hypothesis development and enhance the feasibility of conducting a randomized clinical trial to examine if treatment of insomnia results in participant's being better able to integrate diabetes education into their self-management behavior and result in improved glucose control, 2) explore the associations among changes in insomnia severity, fatigue, daytime sleepiness, sleep quality, A1C (a measure of glucose control over the last three months) and diabetes self-management (DSM) behaviors, 3) explore average pre-intervention to post-intervention changes in insomnia severity, daytime symptoms (fatigue, sleepiness, mood) and DSM behaviors (diet and physical activity) in subjects treated with SHUTi + DSM compared to IC + DSM subjects at 3 months, and 4) explore sleep fragmentation as a potential physiological mechanism linking impaired glucose control (A1C) and sleep in subjects with insomnia and T2DM at baseline and 3 months.

Interventions

BEHAVIORALInsomnia Intervention

The SHUTi intervention is based on a cognitive behavioral treatment for insomnia (CBT-I) and organized into six structured, weekly online sessions. Each week the participants will complete a 30-minute interactive learning module and to complete daily online sleep diaries will be used.

Information on websites that are general health promoting

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Two group design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* (1) T2DM with suboptimal glucose control * (2) age 18 years or older; * (3) willing to be randomized to SHUTi or IC group; * (4) able to speak, read, and write in English, and * (5) insomnia symptoms with at least one daytime consequence \[e.g. impaired mood, poor sleep quality, excessive daytime sleepiness, fatigue\].

Exclusion criteria

* Type 1 or gestational diabetes * Change in oral medications or \> 10% change in insulin in last 3 months * Acute medical or psychiatric illness or hospitalization ≤ 3 months (such as angina, stroke, major surgery, major depression or serious psychiatric conditions) * AHI (apnea-hypopnea index; apnea \[cessation of breathing\] or hypopnea \[reduction in breathing\]) ≥ 10 episodes an hour on overnight sleep study * Non-ambulatory * Self-reported epilepsy, psychotic or bipolar disorder * History of near-miss or auto accident during last 12 months * Employed in safety sensitive job (e.g. truck driver or airline pilot) * Working nights or rotating shifts * Regular use of alerting (e.g., modafinil) medications * Consumption of alcohol: Men: \> 4 drinks a day or \> 14 drinks per week * Women: \> 3 drinks a day or \> 7 drinks per week * If using sleep medications, the drug and/or dose changed in the past month * Depression * Medications for psychotic or bipolar disorders * No internet access * Pregnant or intend to become pregnant in the next four months (postmenopausal or confirmed not pregnant by a urine pregnancy test)

Design outcomes

Primary

MeasureTime frameDescription
Average Glucose Control for Last 3 Months Assessed by A!C levelAfter 12 weeks of either the insomnia intervention or the information control interventionA1C level

Secondary

MeasureTime frameDescription
Sleep QualityAfter 12 weeks of either the insomnia intervention or the information control interventionScores on the Pittsburgh Sleep Quality Index questionnaire

Other

MeasureTime frameDescription
Insomnia SeverityAfter 12 weeks of either the insomnia intervention or the information control interventionScores on the Insomnia Severity Index questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026